Thursday 21 August 2014
 
»
Tag
 
»
Sanofi

PE firms mull $10bn merger of older GSK, Sanofi brands

Private equity firms are mulling over a $10 billion plan to buy and merge older drug brands of Britain's GlaxoSmithKline and France's Sanofi, the Financial Times reported on Sunday, citing sources. U.S.-based KKR and Warbu

More…

Dubai Investments sells 66pc stake in pharma group

Dubai Investments (DI), a leading investment company, said it has sold 66 per cent equity stake in its pharmaceutical subsidiary Globalpharma Company to a group led by healthcare giant Sanofi. Globalpharma is a key manufacturer of

More…

Dubai Investments sells 66pc stake in pharma group

Dubai Investments (DI), a leading investment company, said it has sold 66 per cent equity stake in its pharmaceutical subsidiary Globalpharma Company to a group led by healthcare giant Sanofi. Globalpharma is a key manufacturer of

More…

New Sanofi treatment approved for type 2 diabetes

A new treatment for adults with type 2 diabetes mellitus to achieve glycemic control is available in the UAE with the approval of Sanofi’s Lyxumia (lixisenatide). Lyxumia helps to achieve glycemic control in combination with

More…

Sanofi MS drug nears EU green light

One of the world's longest running drug development sagas may draw to a close this month as French firm Sanofi hopes for a European green light for its new multiple sclerosis medicine Lemtrada. The drug's quarter-century j

More…

DHA spearheads breast cancer campaign

Dubai Health Authority has joined forces with pharma group Sanofi and technology giant Philips to launch its breast cancer awareness campaign which will run till the end of this month. As part of the initiative, free screenings wi

More…

Mobily, Sanofi in Saudi mHealth tieup

Saudi telecom services operator Etihad telecom (Mobily) has joined hands with Sanofi, a global health care leader to boost its mobilized healthcare services (mHealth) with an innovative approach.   Sanofi and Mobily said the p

More…

Sanofi says MS treatment reduced relapse rate

Sanofi said on Friday a trial of its multiple-sclerosis treatment teriflunomide found that a daily dose of the drug reduced the rate of relapse by 36 per cent compared with a placebo. Teriflunomide, marketed as Aubagio, is one of the two m

More…

Sanofi strong in emerging markets as rivals flag

French drugmaker Sanofi posted better-than-expected quarterly results, bolstered by strong emerging markets, breaking with a trend of earnings misses by European rivals AstraZeneca and GlaxoSmithkline. Sanofi performed strongly in Chi

More…

Hospital marks recovery of cancer patients

The Dubai Hospital recently held an event to mark the recovery of 450 cancer patients aged 2 to 22 years. Hussain Abdul Rehman, medical director of Dubai Hospital said: “This is a tough battle and each of these patients and their family me

More…
 1 2 3 4 5 >  Last ›

calendarCalendar of Events

Ads